Human cerebral collateral arteriole function in subjects with normal cognition, mild cognitive impairment, and dementia
Name:
114881_1_merged_1525366236.pdf
Size:
726.0Kb
Format:
PDF
Description:
Final Accepted Manuscript
Author
Migrino, Raymond Q.Truran, Seth
Karamanova, Nina
Serrano, Geidy E.
Madrigal, Calvin
Davies, Hannah A.
Madine, Jillian
Reaven, Peter
Beach, Thomas G.
Affiliation
Univ Arizona, Coll Med Phoenix, Dept MedIssue Date
2018-08Keywords
Alzheimer's diseasecerebrovascular disease
disease model
endothelial function
vascular dementia
Metadata
Show full item recordPublisher
AMER PHYSIOLOGICAL SOCCitation
Human cerebral collateral arteriole function in subjects with normal cognition, mild cognitive impairment, and dementia Raymond Q. Migrino, Seth Truran, Nina Karamanova, Geidy E. Serrano, Calvin Madrigal, Hannah A. Davies, Jillian Madine, Peter Reaven, and Thomas G. Beach American Journal of Physiology-Heart and Circulatory Physiology 2018 315:2, H284-H290Rights
Copyright © 2018, The American Physiological Society.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Clinical and preclinical studies have suggested a link between cardiovascular disease and dementia disorders. but the role of the collateral brain circulation in cognitive dysfunction remains unknown. We aimed to test the hypothesis that leptomeningeal arteriole (LMA) function and response to metabolic stressors differ among subjects with dementia, mild cognitive impairment (MCI), and normal cognition (CN). After rapid autopsy, LMAs were isolated from subjects with CN (n = 10). MCI (n = 12), or dementia [n = 42, Alzheimer's disease (AD), vascular dementia (VaD), or other dementia], and endothelial and smooth muscle-dependent function were measured at baseline and after exposure to beta-amyloid (2 mu M), palmitic acid (150 mu M), or medin (5 mu M) and compared. There were no differences among the groups in baseline endothelial function (maximum dilation to acetylcholine, CN: 74.1 +/- 9.7%, MCI: 67.1 +/- 4.8%, AD: 74.7 +/- 2.8%, VaD: 72.0 +/- 5.3%, and other dementia: 68.0 +/- 8.0%) and smooth muscle-dependent function (CN: 93.4 +/- 3.0%. MCI: 83.3 +/- 4.1%, AD: 91.8 +/- 1.7%, VaD: 91.7 +/- 2.4%, and other dementia: 87.9 +/- 4.9%). There was no correlation between last cognitive function score and baseline endothelial or smooth muscledependent function. LMA endothelial function and, to a lesser extent. smooth muscle-dependent function were impaired posttreatment with -amyloid, palmitic acid, and mexlin. Posttreatment LMA responses were not different between subjects with CN/MCI vs. dementia. Baseline responses and impaired vasoreactivity after treatment with metabolic stressors did not differ among subjects with CN, MCI, and dementia. The results suggest that the cognitive dysfunction in dementia disorders is not attributable to differences in baseline brain collateral circulation function but may be influenced by exposure of the vasculature to metabolic stressors. NEW & NOTEWORTHY Here, we present novel findings that brain collateral arteriole function did not differ among subjects with normal cognition, mild cognitive impairment, and dementia (Alzheimer's disease and vascular dementia). Although arteriole function was impaired by vascular stressors (beta-amyloid, palmitic acid, and medin), responses did not differ between those with or without dementia. The cognitive dysfunction in dementia disorders is not attributable to differences in baseline brain collateral circulation function but may be influenced by vascular exposure to metabolic stressors.Note
12 month embargo; published online: 1 August 2018ISSN
0363-61351522-1539
PubMed ID
29775413Version
Final accepted manuscriptSponsors
National Institutes of Health [R21-AG-044723, U24-NS-072026, P30-AG-19610, RO1-AG-019795]; Veterans Affairs Merit Award [BX-003767, BX007080]; British Heart Foundation [FS/12/61/29877]; Arizona Department of Health Services, Arizona Biomedical Research Commission [4001/0011/05-901/1001]; Michael J. Fox Foundation for Parkinson's Research; United States Department of Defense Grant [AZ160056]Additional Links
https://www.physiology.org/doi/10.1152/ajpheart.00206.2018ae974a485f413a2113503eed53cd6c53
10.1152/ajpheart.00206.2018
Scopus Count
Collections
Related articles
- Adipose and leptomeningeal arteriole endothelial dysfunction induced by β-amyloid peptide: a practical human model to study Alzheimer's disease vasculopathy.
- Authors: Truran S, Franco DA, Roher AE, Beach TG, Burciu C, Serrano G, Maarouf CL, Schwab S, Anderson J, Georges J, Reaven P, Migrino RQ
- Issue date: 2014 Sep 30
- Progression of mild cognitive impairment to Alzheimer's or vascular dementia versus normative aging among elderly Chinese.
- Authors: Huang J, Meyer JS, Zhang Z, Wei J, Hong X, Wang J, Wen H, Wu W, Wu J, Chowdhury MH
- Issue date: 2005 Dec
- MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias.
- Authors: Meyer JS, Huang J, Chowdhury MH
- Issue date: 2007 Jun 15
- Cerebrovascular medin is associated with Alzheimer's disease and vascular dementia.
- Authors: Migrino RQ, Karamanova N, Truran S, Serrano GE, Davies HA, Madine J, Beach TG
- Issue date: 2020
- Cerebrovascular Hemodynamics in Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Transcranial Doppler Studies.
- Authors: Fresnais D, Ihle-Hansen H, Lundström E, Andersson ÅG, Fure B
- Issue date: 2023
